Impact of macrolide therapy on mortality in severe sepsis caused by pneumonia.
van der Eerden
M M
MM
Boersma
W G
WG
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001988:Bronchiolitis / Q000150:complications / Q000628:therapy; D017714:Community-Acquired Infections / Q000150:complications / Q000188:drug therapy / Q000401:mortality; D003422:Critical Care; D003550:Cystic Fibrosis / Q000150:complications / Q000628:therapy; D006801:Humans; D007249:Inflammation; D018942:Macrolides / Q000627:therapeutic use*; D011014:Pneumonia / Q000150:complications* / Q000188:drug therapy / Q000401:mortality; D016032:Randomized Controlled Trials as Topic; D018805:Sepsis / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality*; D016896:Treatment Outcome; D047090:beta-Lactams / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D018942:Macrolides; D047090:beta-Lactams